Boris Feldman is a partner at Freshfields Bruckhaus Deringer LLP.
Historically, bubbles are followed by suits. After the Dot-Com Boom came the Dot-Com Bust, along with years of shareholder litigation. Ditto for the Credit Crunch. As we emerge from The Lockdown, SPACs are enjoying roaring popularity in the capital markets. Presumably, at some point the market will turn. Some SPACs no doubt will perform well and become models of business success. For those SPACs that do not thrive after going public, one can anticipate that the plaintiffs’ securities bar will be innovative in devising claims. This post is not about that.
Rather, this post ponders what a wave of SPAC shareholder suits may mean for the Directors and Officers Liability Insurance industry. My hypothesis is that, in the coming years, we may experience a volume of coverage disputes not seen in the shareholder litigation world since the individual/entity allocation battles of the 1990s. These disputes may be, not just between insured and insurer, but also between the different towers of insurance implicated by the lawsuits. Before the wave comes ashore, it may be useful for future participants to contemplate which conflicts will emerge and how they might play out.